FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to ophthalmology, and is intended for inhibiting and complex treatment of intraoperative macular oedema. Pharmaceutical composition contains keratan sulphate, chondroitin sulphate sodium salt, phosphatidyl choline and saline solution. Ingredients are used in declared ratio.
EFFECT: using invention provides higher visual acuity of patient due to reduction of intensity of inflammatory response, vascular permeability and accumulation of fluid in extracellular space.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR INTEGRATED TREATMENT OF PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AND OCULAR SURFACE DISEASES | 2011 |
|
RU2464985C1 |
| COMPOSITION FOR INTEGRATED TREATMENT OF PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AND OCULAR SURFACE DISEASES | 2013 |
|
RU2517033C1 |
| PHARMACEUTICAL COMPOSITION FOR INTEGRATED TREATMENT OF OCULAR SURFACE DISEASES IN PATIENTS SUFFERING PRIMARY OPEN-ANGLE GLAUCOMA | 2011 |
|
RU2460517C1 |
| EYE DROPS FOR TREATING DRY EYE SYNDROME | 2006 |
|
RU2302231C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES AND EYE CORNEA INJURIES | 2004 |
|
RU2259833C1 |
| MACULAR RUPTURE SURGERY TECHNIQUE | 2016 |
|
RU2620929C1 |
| PHARMACOLOGICALLY ACTIVE SUBSTANCE FOR OPHTHALMOLOGY | 2004 |
|
RU2272635C1 |
| METHOD FOR SURGICAL TREATMENT OF MACULAR RETINA RUPTURES | 2018 |
|
RU2698633C1 |
| METHOD FOR SURGICAL TREATMENT OF MACULAR RETINAL TEAR | 2021 |
|
RU2773204C1 |
| METHOD OF DEFINING INDICATIONS FOR SURGICAL TREATMENT OF CENTRAL RETINAL VEIN BRANCH THROMBOSIS | 2008 |
|
RU2357711C1 |
